Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients

Background: Although various effective compounds for the second- and third-line treatment of advanced or recurrent cervical cancer improved the overall survival, the optimal regimen remains controversial. Previous studies revealed that apatinib had extensive anti-tumor activities. However, almost al...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Da, He, Qionghua, Zhai, Lingyun, Shen, Jiayu, Jing, Fei, Chen, Huanhuan, Zhu, Xiaoqing, Zhou, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403417/
https://www.ncbi.nlm.nih.gov/pubmed/36034824
http://dx.doi.org/10.3389/fphar.2022.843905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403417/
https://www.ncbi.nlm.nih.gov/pubmed/36034824
http://dx.doi.org/10.3389/fphar.2022.843905

Ejemplares similares